Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 8INDUSTRY 2NIH 1INDIV 1

Study Type

Interventional 44Observational 2

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 1Dementia 1Alzheimer Disease 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Methotrexate × Clear all
NCT04571697 2025-04-27

A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

Janssen Research & Development, LLC

Completed
34,647 enrolled

Alzheimer Disease, Dementia

NCT02383901 2016-09-05

FORTO

Isofol Medical AB

Completed
116 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡